{"id":"https://openalex.org/W4400101064","doi":"https://doi.org/10.1111/bcp.16145","title":"Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram\u2010negative bacterial infections","display_name":"Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram\u2010negative bacterial infections","publication_year":2024,"publication_date":"2024-06-26","ids":{"openalex":"https://openalex.org/W4400101064","doi":"https://doi.org/10.1111/bcp.16145","pmid":"https://pubmed.ncbi.nlm.nih.gov/38925918"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.16145","doi":"https://doi.org/10.1111/bcp.16145","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.16145","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://discovery.ucl.ac.uk/id/eprint/10195617/1/Della%20Pasqua_Vaborem%20PKPD_paediatrics_Manuscript_Final_for%20post-acceptance.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005667457","display_name":"Chiara Fornari","orcid":"https://orcid.org/0000-0001-9334-8513","observed_orcids":["https://orcid.org/0000-0001-9334-8513"]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Chiara Fornari","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":"https://orcid.org/0000-0001-9334-8513","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041606755","display_name":"Antonio Carlos Arrieta","orcid":"https://orcid.org/0000-0001-9281-8915","observed_orcids":["https://orcid.org/0000-0001-9281-8915"]},"institutions":[{"id":"https://openalex.org/I1304278710","display_name":"Children's Hospital of Orange County","ror":"https://ror.org/0282qcz50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304278710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Arrieta","raw_affiliation_strings":["Children's Hospital of Orange County, Orange, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital of Orange County, Orange, California, USA","institution_ids":["https://openalex.org/I1304278710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019823948","display_name":"John S. Bradley","orcid":"https://orcid.org/0000-0002-3835-5064","observed_orcids":["https://orcid.org/0000-0002-3835-5064","https://orcid.org/0000-0001-6963-9978"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210087384","display_name":"Rady Children's Hospital-San Diego","ror":"https://ror.org/00414dg76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John S. Bradley","raw_affiliation_strings":["Division of Infectious Diseases, Department of Pediatrics, University of California San Diego, San Diego, California, USA","Rady Children's Hospital, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Pediatrics, University of California San Diego, San Diego, California, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Rady Children's Hospital, San Diego, California, USA","institution_ids":["https://openalex.org/I4210087384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027692619","display_name":"Mira Tout","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mira Tout","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103727172","display_name":"Paulo Jorge Magalh\u00e3es","orcid":"https://orcid.org/0009-0009-0259-6171","observed_orcids":["https://orcid.org/0009-0009-0259-6171"]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paulo Magalhaes","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020618792","display_name":"Faten Kora\u00efchi","orcid":"https://orcid.org/0000-0002-8636-6411","observed_orcids":["https://orcid.org/0000-0002-8636-6411"]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Faten Koraichi Auriol","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051554980","display_name":"Elisa Borella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Borella","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058797459","display_name":"Chiara Piana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Piana","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081960928","display_name":"Oscar E. Della Pasqua","orcid":"https://orcid.org/0000-0002-6211-1430","observed_orcids":["https://orcid.org/0000-0002-6211-1430"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Oscar Della Pasqua","raw_affiliation_strings":["Clinical Pharmacology & Therapeutics University College London London UK"],"raw_orcid":"https://orcid.org/0000-0002-6211-1430","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology & Therapeutics University College London London UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004289593","display_name":"Bartomeu Piz\u00e0 Vallespir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Bartomeu Piza Vallespir","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111456678","display_name":"Paolo Mazzei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Mazzei","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085954949","display_name":"Paula M. Bokesch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128966","display_name":"Melinta Therapeutics (United States)","ror":"https://ror.org/02e451q69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210128966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula M. Bokesch","raw_affiliation_strings":["Melinta Therapeutics, LLC, Lincolnshire, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melinta Therapeutics, LLC, Lincolnshire, Illinois, USA","institution_ids":["https://openalex.org/I4210128966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083400010","display_name":"Randall K. Hoover","orcid":"https://orcid.org/0000-0002-5852-606X","observed_orcids":["https://orcid.org/0000-0002-5852-606X"]},"institutions":[{"id":"https://openalex.org/I4210128966","display_name":"Melinta Therapeutics (United States)","ror":"https://ror.org/02e451q69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210128966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randall Hoover","raw_affiliation_strings":["Melinta Therapeutics, LLC, Lincolnshire, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melinta Therapeutics, LLC, Lincolnshire, Illinois, USA","institution_ids":["https://openalex.org/I4210128966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967157","display_name":"Angela Capriati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angela Capriati","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049730819","display_name":"Nassir Habboubi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nassir Habboubi","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and Clinical DMPK Department, Stemline Therapeutics/Menarini Group, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5005667457"],"corresponding_institution_ids":["https://openalex.org/I4210108499"],"apc_list":{"value":4550,"currency":"USD","value_usd":4550},"apc_paid":null,"fwci":1.7437,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.82729974,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"90","issue":"10","first_page":"2597","last_page":"2610"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.03739999979734421,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meropenem-vaborbactam","display_name":"meropenem-vaborbactam","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pediatric-pharmacokinetics","display_name":"pediatric pharmacokinetics","score":0.9039999842643738},{"id":"https://openalex.org/keywords/gram-negative-infections","display_name":"gram-negative bacterial infection","score":0.7630000114440918},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6579999923706055},{"id":"https://openalex.org/keywords/probability-of-target-attainment","display_name":"probability of target attainment","score":0.9629999995231628},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.7020000219345093},{"id":"https://openalex.org/keywords/neonates-and-infants","display_name":"neonates and infants","score":0.8429999947547913},{"id":"https://openalex.org/keywords/body-weight-covariate","display_name":"body weight covariate","score":0.7570000290870667},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.597000002861023},{"id":"https://openalex.org/keywords/pediatric-drug-development","display_name":"pediatric drug development","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8069090843200684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7901473045349121},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.692630410194397},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5782725811004639},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4482538402080536},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33236417174339294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3214435875415802},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.26337140798568726},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.10263103246688843},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077731","descriptor_name":"Meropenem","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077731","descriptor_name":"Meropenem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006573","descriptor_name":"Heterocyclic Compounds, 1-Ring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016905","descriptor_name":"Gram-Negative Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.16145","doi":"https://doi.org/10.1111/bcp.16145","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.16145","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:38925918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38925918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10195617","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10195617/","pdf_url":"https://discovery.ucl.ac.uk/id/eprint/10195617/1/Della%20Pasqua_Vaborem%20PKPD_paediatrics_Manuscript_Final_for%20post-acceptance.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Clinical Pharmacology , 90 (10) pp. 2597-2610. (2024)","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10195617","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10195617/","pdf_url":"https://discovery.ucl.ac.uk/id/eprint/10195617/1/Della%20Pasqua_Vaborem%20PKPD_paediatrics_Manuscript_Final_for%20post-acceptance.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Clinical Pharmacology , 90 (10) pp. 2597-2610. (2024)","raw_type":"Article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400101064.pdf","grobid_xml":"https://content.openalex.org/works/W4400101064.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1556440220","https://openalex.org/W1820140377","https://openalex.org/W1822390790","https://openalex.org/W1960255425","https://openalex.org/W1965987183","https://openalex.org/W2009450226","https://openalex.org/W2020365240","https://openalex.org/W2070879176","https://openalex.org/W2076110457","https://openalex.org/W2088996598","https://openalex.org/W2089051496","https://openalex.org/W2091277908","https://openalex.org/W2110612372","https://openalex.org/W2117059723","https://openalex.org/W2120416054","https://openalex.org/W2121276534","https://openalex.org/W2122855609","https://openalex.org/W2151811124","https://openalex.org/W2153093832","https://openalex.org/W2167469281","https://openalex.org/W2181278642","https://openalex.org/W2339648279","https://openalex.org/W2471164591","https://openalex.org/W2517402958","https://openalex.org/W2522933058","https://openalex.org/W2540968481","https://openalex.org/W2559143299","https://openalex.org/W2754579997","https://openalex.org/W2888126110","https://openalex.org/W2889629084","https://openalex.org/W2891065127","https://openalex.org/W2899682145","https://openalex.org/W2972951609","https://openalex.org/W2987002164","https://openalex.org/W3025910342","https://openalex.org/W3035086248","https://openalex.org/W3090051413","https://openalex.org/W3090077807","https://openalex.org/W3159592417","https://openalex.org/W3167569665","https://openalex.org/W3173510633","https://openalex.org/W3194223471","https://openalex.org/W3194319661","https://openalex.org/W3211322813","https://openalex.org/W4206120524","https://openalex.org/W4210346807"],"related_works":["https://openalex.org/W2123003250","https://openalex.org/W2133190300","https://openalex.org/W7171613979","https://openalex.org/W2748061698","https://openalex.org/W2084922281","https://openalex.org/W2073286531","https://openalex.org/W4389031011","https://openalex.org/W2754579997","https://openalex.org/W3041908833","https://openalex.org/W6987819482"],"abstract_inverted_index":{"AIMS:":[0],"Meropenem/vaborbactam":[1,130],"combination":[2],"is":[3,203],"approved":[4],"in":[5,33,37,49,65,75,102,108,161,163,236,245],"adults":[6,103],"by":[7,17],"FDA":[8],"and":[9,16,39,59,142,185,187,215,225,239,247],"EMA":[10,18],"for":[11,20,86,169,191,213,242],"complicated":[12],"urinary":[13],"tract":[14],"infections":[15],"also":[19],"other":[21],"Gram-negative":[22],"infections.":[23],"We":[24],"aimed":[25],"to":[26,44,81,104,113,121,158],"characterise":[27],"the":[28,115,148,243],"pharmacokinetics":[29],"of":[30,57,117,125,150,178,182,196,210,223,231],"both":[31,151,183],"moieties":[32],"an":[34],"ongoing":[35],"study":[36],"children":[38,170],"use":[40],"a":[41,93,99,206],"model-based":[42],"approach":[43],"inform":[45,105],"adequate":[46,123,201],"dosing":[47,119,244],"regimens":[48,120],"paediatric":[50,76,226,237],"patients.":[51],"METHODS:":[52],"Over":[53],"4196":[54],"blood":[55,70],"samples":[56,71],"meropenem":[58,184],"vaborbactam":[60,186],"(n":[61,72],"=":[62,73],"414":[63],"subjects)":[64],"adults,":[66],"together":[67],"with":[68,95,134,137],"114":[69],"39)":[74],"patients":[77,238],"aged":[78,171],"3":[79],"months":[80,173],"18":[82],"years":[83],"were":[84,90,111,144],"available":[85],"this":[87],"analysis.":[88],"Data":[89],"analysed":[91],"using":[92],"population":[94],"prior":[96],"information":[97],"from":[98],"pharmacokinetic":[100],"model":[101],"parameter":[106],"estimation":[107],"children.":[109],"Simulations":[110],"performed":[112],"assess":[114],"suitability":[116],"different":[118],"achieve":[122],"probability":[124],"target":[126],"attainment":[127],"(PTA).":[128],"RESULTS:":[129],"PK":[131,235],"was":[132,156,167],"described":[133],"two-compartment":[135],"models":[136],"first-order":[138],"elimination.":[139],"Body":[140],"weight":[141],"CLcr":[143],"significant":[145],"covariates":[146],"on":[147],"disposition":[149,197],"drugs.":[152],"A":[153],"maturation":[154],"function":[155],"evaluated":[157],"explore":[159],"changes":[160],"clearance":[162],"neonates.":[164],"PTA":[165,202],"\u226590%":[166],"derived":[168],"\u22653":[172],"after":[174,205],"3.5-h":[175,207],"IV":[176,208],"infusion":[177,209],"40":[179],"mg/kg":[180,212],"Q8h":[181],"2":[188],"g/2":[189],"g":[190],"those":[192],"\u226550":[193],"kg.":[194],"Extrapolation":[195],"parameters":[198],"suggest":[199],"that":[200],"achieved":[204],"20":[211],"neonates":[214,246],"infants":[216,248],"(3":[217,249],"months).":[218,250],"CONCLUSIONS:":[219],"An":[220],"integrated":[221],"analysis":[222],"adult":[224],"data":[227],"allowed":[228],"accurate":[229],"description":[230],"sparsely":[232],"sampled":[233],"meropenem/vaborbactam":[234],"provided":[240],"recommendations":[241]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-28T00:00:00"}